Correction: Reduced Fc-mediated antibody responses after COVID-19 mRNA vaccination in a cohort of people living with HIV-1

Key Points

• Antibody responses were significantly reduced after mRNA vaccination, indicating potential immune challenges for people living with HIV-1.
• Participants living with HIV-1 exhibited lower Fc-mediated responses compared to non-infected individuals, with differences noted in immunogenicity.
• Assessment of immune response metrics revealed limitations in vaccine efficacy among HIV-1 cohorts, emphasizing the need for tailored interventions.
• This finding highlights the requirement for further investigation into mRNA vaccine adaptations to improve immunity for immunocompromised groups.